Investors Can Lead Dun & Bradstreet Securities Fraud Lawsuit

Rosen Law Firm, an international investor rights law firm, has notified investors in Dun & Bradstreet Holdings, Inc. (NYSE: DNB) of the opportunity to lead a securities fraud class action lawsuit. The action concerns D&B common stock sold between May 13, 2025, and August 26, 2025, as well as shares exchanged in the company's August 2025 merger with affiliates of Clearlake Capital Group for $9.15 per share.

The lawsuit alleges that D&B's merger announcement in March 2025 and its proxy statement filed in May 2025 contained false and misleading statements. Specifically, the complaint claims that the proxy materials omitted information about the company's true value and failed to disclose the executive chairman's personal interest in a swift sale. It also alleges that valuations of superior alternatives to a whole-company sale by Bank of America Securities were omitted, and that downward revisions to D&B's financial projections, approved by the board, were not disclosed.

Investors who sold D&B stock during the specified period, exchanged shares in the merger, or held shares as of May 9, 2025, and voted on the merger may be entitled to compensation without out-of-pocket fees. Rosen Law Firm advises investors to select counsel with a proven track record in securities class actions. The deadline to move the Court to serve as lead plaintiff is November 10, 2026.

A class action lawsuit has already been filed. The litigation seeks to recover damages for investors harmed by the allegedly false and misleading statements. Interested parties can join the action or seek lead plaintiff status by contacting Rosen Law Firm for more information.